After The Stock Rose 9.09% Over The Week, Is Merck & Co. Inc. (NYSE: MRK) Still A Buy? – Marketing Sentinel
Home  »  Company   »  After The Stock Rose 9.09% Over The Week, Is Merck...

After The Stock Rose 9.09% Over The Week, Is Merck & Co. Inc. (NYSE: MRK) Still A Buy?

Merck & Co. Inc. (NYSE:MRK)’s traded shares stood at 4.62 million during the latest session, with the company’s beta value hitting 0.42. At the last check today, the stock’s price was $81.15, to imply a decrease of -0.96% or -$0.79 in intraday trading. The MRK share’s 52-week high remains $84.56, putting it -4.2% down since that peak but still an impressive 15.74% since price per share fell to its 52-week low of $68.38. The company has a valuation of $191.39B, with an average of 32.62 million shares in intraday trading volume over the past 10 days and average of 12.77 million shares over the past 3 months.

Analysts have given a consensus recommendation of an Overweight for Merck & Co. Inc. (MRK), translating to a mean rating of 2.00. Of 21 analyst(s) looking at the stock, 0 analyst(s) give MRK a Sell rating. 5 of those analysts rate the stock as Overweight while 7 advise Hold as 9 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at $1.55.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free


Merck & Co. Inc. (NYSE:MRK) trade information

After registering a -0.96% downside in the latest session, Merck & Co. Inc. (MRK) has traded red over the past five days. The stock hit a weekly high of 84.56 this Thursday, 10/07/21, dropping -0.96% in its intraday price action. The 5-day price performance for the stock is 9.09%, and 8.73% over 30 days. With these gigs, the year-to-date price performance is 5.05%. Short interest in Merck & Co. Inc. (NYSE:MRK) saw shorts transact 22.25 million shares and set a 1.85 days time to cover.

Analysts on Wall Street suggest a consensus price target of $94.89, implying an increase of 14.48% to the stock’s recent value. The extremes give us $82.00 and $107.00 for target low and target high price respectively. As such, MRK has been trading -31.85% off suggested target high and -1.05% from its likely low.

Merck & Co. Inc. (MRK) estimates and forecasts

Looking at statistics comparing Merck & Co. Inc. share performance against respective industry, we note that the company has underperformed competitors. Merck & Co. Inc. (MRK) shares are 12.61% up over the last 6 months, with its year-to-date growth rate lower than industry average at -6.90% against 3.50%. Revenue is forecast to grow 13.10% this quarter before jumping 52.00% for the next one. The rating firms project that company’s revenue will shrink -2.40% compared to the previous financial year.

Revenue forecast for the current quarter as set by 9 analysts is $12.32 billion. Meanwhile, for the quarter ending Dec 2021, a total of 9 analyst(s) estimate revenue growth to $12.41 billion.Earnings reports from the last fiscal year show that sales brought in $12.25 billion and $12.51 billion respectively in the corresponding quarters. In this case, analysts estimate current quarter sales to rise 0.60% before dropping -0.80% in the following quarter.

An assessment of the company’s 5-year growth patterns shows that annual earnings grew an estimated 12.20% for the past 5-year period. While 2021 is set for a -28.00% return in earnings, projections for the next 5 years are at 12.97% annually.

MRK Dividends

Merck & Co. Inc. has its next earnings report out on October 28. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too. Merck & Co. Inc. has a forward dividend ratio of 2.60, with the share yield ticking at 3.17% to continue the rising pattern observed over the past year. The company’s average dividend yield trailing the past 5-year period is 2.94%.

Merck & Co. Inc. (NYSE:MRK)’s Major holders

Merck & Co. Inc. insiders hold 0.08% of total outstanding shares, with institutional holders owning 75.43% of the shares at 75.49% float percentage. In total, 75.43% institutions holds shares in the company, led by Vanguard Group, Inc. (The). As of Mar 30, 2021, the company held over 225.21 million shares (or 8.89% of shares), all amounting to roughly $17.36 billion.

The next major institution holding the largest number of shares is Blackrock Inc. with 193.93 million shares, or about 7.66% of shares outstanding. As of the market price on Mar 30, 2021, these shares were worth $14.95 billion.

>> 7 Top Picks for the Post-Pandemic Economy <<

We also have Vanguard Total Stock Market Index Fund and Vanguard 500 Index Fund as the top two Mutual Funds with the largest holdings of the Merck & Co. Inc. (MRK) shares. Going by data provided on Mar 30, 2021, Vanguard Total Stock Market Index Fund holds roughly 71.33 million shares. This is just over 2.82% of the total shares, with a market valuation of $5.5 billion. Data from the same date shows that the other fund manager holds a little less at 51.81 million, or 2.05% of the shares, all valued at about 3.99 billion.

Get The Best Stocks To Trade Every Day!

Join now to get the pre-market morning brief 100% free

Leave a Comment

Your email address will not be published. Required fields are marked *

On Key

Related Posts



Download Free eBook For



100% free. stop anytime no spam



Download Free eBook For



100% free. stop anytime no spam